Immunic shareholders approved reverse stock split proposal at special meeting
PUBT · 6h ago
Share
Listen to the news
- Immunic held a special shareholder meeting on April 14, 2026.
- Shareholders authorized board to amend charter to implement a reverse stock split within one year, with ratio set within 1-for-10 to 1-for-30.
- Board set reverse split ratio at 1-for-10, effective April 27, 2026.
- Post-split shares are expected to trade on Nasdaq under symbol IMUX starting April 27, 2026.
- New common stock CUSIP will be 4525EP200.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193805-26-000461), on April 14, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved